ANIXA BIOSCIENCES INC Debt to Equity Ratio 2010-2024 | ANIX

Current and historical debt to equity ratio values for ANIXA BIOSCIENCES INC (ANIX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ANIXA BIOSCIENCES INC debt/equity for the three months ending April 30, 2024 was 0.00.
ANIXA BIOSCIENCES INC Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-04-30 $0.00B $0.02B 0.08
2024-01-31 $0.00B $0.02B 0.08
2023-10-31 $0.00B $0.02B 0.09
2023-07-31 $0.00B $0.03B 0.08
2023-04-30 $0.00B $0.03B 0.07
2023-01-31 $0.00B $0.03B 0.05
2022-10-31 $0.00B $0.03B 0.08
2022-07-31 $0.00B $0.03B 0.05
2022-04-30 $0.00B $0.03B 0.04
2022-01-31 $0.00B $0.03B 0.06
2021-10-31 $0.00B $0.04B 0.04
2021-07-31 $0.00B $0.04B 0.03
2021-04-30 $0.00B $0.04B 0.04
2021-01-31 $0.00B $0.01B 0.12
2020-10-31 $0.00B $0.01B 0.14
2020-07-31 $0.00B $0.01B 0.15
2020-04-30 $0.00B $0.01B 0.23
2020-01-31 $0.00B $0.01B 0.23
2019-10-31 $0.00B $0.01B 0.31
2019-07-31 $0.00B $0.01B 0.27
2019-04-30 $0.00B $0.01B 0.26
2019-01-31 $0.00B $0.01B 0.26
2018-10-31 $0.00B $0.01B 0.24
2018-07-31 $0.00B $0.01B 0.18
2018-04-30 $0.00B $0.01B 0.22
2018-01-31 $0.00B $0.01B 0.17
2017-10-31 $0.00B $0.01B 0.11
2017-07-31 $0.00B $0.01B 0.53
2017-04-30 $0.00B $0.00B 1.02
2017-01-31 $0.01B $-0.00B -2.11
2016-10-31 $0.01B $0.00B 4.70
2016-07-31 $0.01B $0.00B 2.68
2016-04-30 $0.01B $0.00B 1.82
2016-01-31 $0.01B $0.00B 1.41
2015-10-31 $0.00B $0.01B 0.85
2015-07-31 $0.00B $0.01B 0.71
2015-04-30 $0.00B $0.01B 0.59
2015-01-31 $0.01B $0.01B 0.61
2014-10-31 $0.01B $0.00B 1.26
2014-07-31 $0.01B $0.00B 88.51
2014-04-30 $0.02B $-0.01B -3.17
2014-01-31 $0.02B $-0.01B -2.82
2013-10-31 $0.01B $-0.00B -2.64
2013-07-31 $0.01B $-0.00B -2.64
2013-04-30 $0.01B $-0.00B -6.09
2013-01-31 $0.01B $-0.00B -6.68
2012-10-31 $0.01B $-0.00B -5.74
2012-07-31 $0.01B $-0.00B -7.59
2012-04-30 $0.01B $0.00B -21.04
2012-01-31 $0.01B $0.00B 9.88
2011-10-31 $0.01B $0.00B 7.17
2011-07-31 $0.01B $0.00B 3.54
2011-04-30 $0.01B $0.00B 1.81
2011-01-31 $0.01B $0.00B 2.08
2010-10-31 $0.01B $0.01B 1.19
2010-07-31 $0.01B $0.00B 1.75
2010-04-30 $0.01B $0.01B 1.13
2010-01-31 $0.01B $0.00B 1.25
2009-10-31 $0.01B $0.00B 1.21
2009-07-31 $0.01B $0.00B 1.82
2009-04-30 $0.01B $0.00B 9.88
2009-01-31 $0.01B $0.00B 15.20
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.103B $0.000B
Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $178.708B 17.88
Vertex Pharmaceuticals (VRTX) United States $126.183B 32.47
Regeneron Pharmaceuticals (REGN) United States $120.652B 29.51
CSL (CSLLY) Australia $100.613B 0.00
Gilead Sciences (GILD) United States $89.253B 17.78
Bristol Myers Squibb (BMY) United States $83.517B 39.24
GSK (GSK) United Kingdom $80.620B 9.63
Moderna (MRNA) United States $47.959B 0.00
Biogen (BIIB) United States $32.762B 15.00
Alnylam Pharmaceuticals (ALNY) United States $31.601B 0.00
Argenex SE (ARGX) Netherlands $28.039B 0.00
BioNTech SE (BNTX) Germany $20.639B 173.64
Illumina (ILMN) United States $19.949B 142.31
Genmab (GMAB) Denmark $17.855B 20.93
BioMarin Pharmaceutical (BMRN) United States $16.309B 63.62
BeiGene (BGNE) Cayman Islands $14.827B 0.00
Incyte (INCY) United States $14.371B 22.22
Sarepta Therapeutics (SRPT) United States $14.082B 1241.50
Bio-Techne Corp (TECH) United States $12.578B 47.51
Insmed (INSM) United States $11.588B 0.00
Legend Biotech (LEGN) United States $10.190B 0.00
QIAGEN (QGEN) Netherlands $9.715B 20.75
Exact Sciences (EXAS) United States $9.166B 0.00
Vaxcyte (PCVX) United States $9.056B 0.00
Roivant Sciences (ROIV) United Kingdom $8.577B 0.00
Intra-Cellular Therapies (ITCI) United States $8.295B 0.00
Ascendis Pharma (ASND) Denmark $8.199B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.085B 26.44
Blueprint Medicines (BPMC) United States $7.545B 0.00
Repligen (RGEN) United States $7.543B 98.54
Zealand Pharma (ZLDPF) Denmark $7.022B 0.00
Halozyme Therapeutics (HALO) United States $7.013B 19.47
Exelixis (EXEL) United States $6.901B 35.56
Viking Therapeutics (VKTX) United States $6.285B 0.00
Krystal Biotech (KRYS) United States $5.956B 0.00
Cytokinetics (CYTK) United States $5.952B 0.00
Nuvalent (NUVL) United States $5.423B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.329B 0.00
Apellis Pharmaceuticals (APLS) United States $4.994B 0.00
Immunovant (IMVT) United States $4.520B 0.00
Avidity Biosciences (RNA) United States $4.464B 0.00
ImmunityBio (IBRX) United States $4.426B 0.00
Alkermes (ALKS) Ireland $4.163B 16.29
Guardant Health (GH) United States $4.140B 0.00
Axsome Therapeutics (AXSM) United States $4.035B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.763B 0.00
Arcellx (ACLX) United States $3.527B 0.00
Merus (MRUS) Netherlands $3.453B 0.00
Twist Bioscience (TWST) United States $3.416B 0.00
Denali Therapeutics (DNLI) United States $3.414B 0.00
Biohaven (BHVN) United States $3.350B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.286B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.250B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.241B 0.00
IDEAYA Biosciences (IDYA) United States $3.228B 0.00
Amicus Therapeutics (FOLD) United States $3.211B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.206B 0.00
ADMA Biologics Inc (ADMA) United States $3.183B 124.82
SpringWorks Therapeutics (SWTX) United States $3.105B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.076B 0.00
Kymera Therapeutics (KYMR) United States $2.975B 0.00
Geron (GERN) United States $2.960B 0.00
Apogee Therapeutics (APGE) United States $2.927B 0.00
Morphic Holding (MORF) United States $2.805B 0.00
MorphoSys AG (MOR) Germany $2.771B 0.00
Certara (CERT) United States $2.654B 61.11
Intellia Therapeutics (NTLA) United States $2.639B 0.00
Celldex Therapeutics (CLDX) United States $2.635B 0.00
Iovance Biotherapeutics (IOVA) United States $2.633B 0.00
Vericel (VCEL) United States $2.538B 0.00
CG Oncology (CGON) United States $2.509B 0.00
Fortrea Holdings (FTRE) United States $2.496B 30.68
Myriad Genetics (MYGN) United States $2.479B 0.00
Janux Therapeutics (JANX) United States $2.405B 0.00
Novavax (NVAX) United States $2.308B 0.00
Beam Therapeutics (BEAM) United States $2.246B 0.00
Arvinas (ARVN) United States $2.240B 0.00
Protagonist Therapeutics (PTGX) United States $2.219B 15.50
Rocket Pharmaceuticals (RCKT) United States $2.120B 0.00
Syndax Pharmaceuticals (SNDX) United States $2.109B 0.00
Bavarian Nordic (BVNRY) Denmark $2.083B 9.07
Structure Therapeutics (GPCR) United States $2.082B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.075B 0.00
NovoCure (NVCR) Jersey $2.075B 0.00
Edgewise Therapeutics (EWTX) United States $2.073B 0.00
Vera Therapeutics (VERA) United States $2.037B 0.00
NeoGenomics (NEO) United States $2.023B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.971B 15.03
Akero Therapeutics (AKRO) United States $1.915B 0.00
Neumora Therapeutics (NMRA) United States $1.895B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.885B 0.00
Keros Therapeutics (KROS) United States $1.883B 0.00
Zai Lab (ZLAB) China $1.851B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.799B 0.00
Ligand Pharmaceuticals (LGND) United States $1.781B 29.10
Kura Oncology (KURA) United States $1.770B 0.00
Galapagos (GLPG) Belgium $1.738B 0.00
MannKind (MNKD) United States $1.634B 200.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.586B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.536B 0.00
Sana Biotechnology (SANA) United States $1.520B 0.00
Belite Bio (BLTE) United States $1.447B 0.00
Arcus Biosciences (RCUS) United States $1.445B 0.00
Dynavax Technologies (DVAX) United States $1.423B 181.17
Day One Biopharmaceuticals (DAWN) United States $1.399B 0.00
Vir Biotechnology (VIR) United States $1.392B 0.00
ANI Pharmaceuticals (ANIP) United States $1.347B 16.73
Gyre Therapeutics (GYRE) United States $1.343B 0.00
Prothena (PRTA) Ireland $1.298B 0.00
Spyre Therapeutics (SYRE) United States $1.247B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.235B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.200B 0.00
Disc Medicine (IRON) United States $1.185B 0.00
Tyra Biosciences (TYRA) United States $1.132B 0.00
Nurix Therapeutics (NRIX) United States $1.121B 0.00
MiMedx (MDXG) United States $1.104B 46.75
Cullinan Therapeutics (CGEM) United States $1.100B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.076B 0.00
Immatics (IMTX) Germany $1.062B 0.00
Tango Therapeutics (TNGX) United States $1.051B 0.00
Humacyte (HUMA) United States $1.047B 0.00
AbCellera Biologics (ABCL) Canada $1.026B 0.00
Viridian Therapeutics (VRDN) United States $1.019B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.001B 0.00
Liquidia Technologies (LQDA) United States $0.980B 0.00
Rapport Therapeutics (RAPP) $0.975B 0.00
AnaptysBio (ANAB) United States $0.942B 0.00
Praxis Precision Medicines (PRAX) United States $0.909B 0.00
Cogent Biosciences (COGT) United States $0.908B 0.00
89BIO (ETNB) United States $0.907B 0.00
Immunome (IMNM) United States $0.879B 0.00
Mesoblast (MESO) Australia $0.876B 0.00
Cytek Biosciences (CTKB) United States $0.874B 0.00
Nuvation Bio (NUVB) United States $0.853B 0.00
CARGO Therapeutics (CRGX) United States $0.848B 0.00
Abivax SA (ABVX) France $0.846B 0.00
Dianthus Therapeutics (DNTH) United States $0.836B 0.00
Olema Pharmaceuticals (OLMA) United States $0.821B 0.00
Pliant Therapeutics (PLRX) United States $0.814B 0.00
Prime Medicine (PRME) United States $0.804B 0.00
CureVac (CVAC) Germany $0.797B 0.00
Travere Therapeutics (TVTX) United States $0.778B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.774B 0.00
Tectonic Therapeutic (TECX) United States $0.772B 0.00
Stoke Therapeutics (STOK) United States $0.768B 0.00
Scholar Rock Holding (SRRK) United States $0.743B 0.00
Oric Pharmaceuticals (ORIC) United States $0.741B 0.00
WAVE Life Sciences (WVE) Singapore $0.734B 0.00
Arbutus Biopharma (ABUS) United States $0.732B 0.00
Zymeworks (ZYME) United States $0.732B 0.00
Allogene Therapeutics (ALLO) United States $0.732B 0.00
Mineralys Therapeutics (MLYS) United States $0.724B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.715B 0.00
ACELYRIN, INC (SLRN) United States $0.699B 0.00
IGM Biosciences (IGMS) United States $0.691B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.684B 0.00
Replimune (REPL) United States $0.679B 0.00
REGENXBIO (RGNX) United States $0.668B 0.00
ArriVent BioPharma (AVBP) United States $0.664B 0.00
Celcuity (CELC) United States $0.656B 0.00
Adaptive Biotechnologies (ADPT) United States $0.656B 0.00
Astria Therapeutics (ATXS) United States $0.650B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Applied Therapeutics (APLT) United States $0.643B 0.00
Emergent Biosolutions (EBS) United States $0.635B 0.00
ITeos Therapeutics (ITOS) United States $0.634B 0.00
Terns Pharmaceuticals (TERN) United States $0.627B 0.00
GH Research (GHRS) Ireland $0.618B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.610B 0.00
Avid Bioservices (CDMO) United States $0.606B 0.00
GRAIL (GRAL) United States $0.604B 0.00
Entrada Therapeutics (TRDA) United States $0.600B 28.19
Neurogene (NGNE) United States $0.594B 0.00
Alector (ALEC) United States $0.586B 0.00
PepGen (PEPG) United States $0.584B 0.00
Pharming Group (PHAR) Netherlands $0.574B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.574B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.574B 0.00
Annexon (ANNX) United States $0.571B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.571B 0.00
Erasca (ERAS) United States $0.560B 0.00
Contineum Therapeutics (CTNM) United States $0.559B 0.00
PureTech Health (PRTC) United States $0.555B 0.00
Pharming Group (PHGUF) Netherlands $0.555B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.549B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.549B 0.00
Castle Biosciences (CSTL) United States $0.539B 0.00
Fulcrum Therapeutics (FULC) United States $0.538B 0.00
Third Harmonic Bio (THRD) United States $0.532B 0.00
MaxCyte (MXCT) United States $0.530B 0.00
Fate Therapeutics (FATE) United States $0.518B 0.00
Alumis (ALMS) United States $0.517B 0.00
C4 Therapeutics (CCCC) United States $0.508B 0.00
Ocugen (OCGN) United States $0.502B 0.00
Voyager Therapeutics (VYGR) United States $0.494B 0.00
Anavex Life Sciences (AVXL) United States $0.493B 0.00
Absci (ABSI) United States $0.492B 0.00
Editas Medicine (EDIT) United States $0.490B 0.00
Northwest Biotherapeutics (NWBO) United States $0.487B 0.00
Kyverna Therapeutics (KYTX) United States $0.477B 0.00
Oculis Holding AG (OCS) Switzerland $0.475B 0.00
Precigen (PGEN) United States $0.475B 0.00
Aura Biosciences (AURA) United States $0.458B 0.00
UniQure (QURE) Netherlands $0.447B 0.00
Revance Therapeutics (RVNC) United States $0.444B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.427B 0.00
ALX Oncology Holdings (ALXO) United States $0.424B 0.00
Alto Neuroscience (ANRO) United States $0.417B 0.00
Anika Therapeutics (ANIK) United States $0.416B 356.88
Urogen Pharma (URGN) United States $0.404B 0.00
EnGene Holdings (ENGN) United States $0.398B 0.00
TScan Therapeutics (TCRX) United States $0.396B 0.00
Nkarta (NKTX) United States $0.395B 0.00
AC Immune (ACIU) Switzerland $0.384B 0.00
Cabaletta Bio (CABA) United States $0.379B 0.00
Agenus (AGEN) United States $0.372B 0.00
Solid Biosciences (SLDB) United States $0.370B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.363B 0.00
Inozyme Pharma (INZY) United States $0.357B 0.00
Scilex Holding (SCLX) United States $0.355B 0.00
Nautilus Biotechnology (NAUT) United States $0.342B 0.00
Poseida Therapeutics (PSTX) United States $0.336B 0.00
Kamada (KMDA) Israel $0.335B 25.30
Sutro Biopharma (STRO) United States $0.333B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.332B 0.00
Jasper Therapeutics (JSPR) United States $0.325B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.325B 0.00
Amarin (AMRN) Ireland $0.324B 0.00
Atea Pharmaceuticals (AVIR) United States $0.323B 0.00
Cartesian Therapeutics (RNAC) United States $0.320B 0.00
Q32 Bio (QTTB) United States $0.319B 0.00
XOMA Royalty (XOMA) United States $0.314B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.313B 0.00
MeiraGTx Holdings (MGTX) United States $0.313B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.305B 0.00
Tenaya Therapeutics (TNYA) United States $0.298B 0.00
Alimera Sciences (ALIM) United States $0.292B 0.00
Inovio Pharmaceuticals (INO) United States $0.288B 0.00
Gossamer Bio (GOSS) United States $0.283B 0.00
Mersana Therapeutics (MRSN) United States $0.275B 0.00
CorMedix Inc (CRMD) United States $0.275B 0.00
Codexis (CDXS) United States $0.262B 0.00
Design Therapeutics (DSGN) United States $0.257B 0.00
2seventy Bio (TSVT) United States $0.252B 0.00
23andMe Holding (ME) United States $0.248B 0.00
Caribou Biosciences (CRBU) United States $0.247B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.246B 0.00
Prima BioMed (IMMP) Australia $0.241B 0.00
Molecular Partners AG (MOLN) Switzerland $0.233B 0.00
ChromaDex (CDXC) United States $0.232B 0.00
Shattuck Labs (STTK) United States $0.231B 0.00
Ventyx Biosciences (VTYX) United States $0.226B 0.00
GENFIT S.A (GNFT) France $0.222B 0.00
Abeona Therapeutics (ABEO) United States $0.219B 0.00
Candel Therapeutics (CADL) United States $0.217B 0.00
Oncobiologics (OTLK) United States $0.216B 0.00
Generation Bio (GBIO) United States $0.212B 0.00
Renovaro (RENB) United States $0.209B 0.00
Inhibrx Biosciences (INBX) $0.209B 0.00
Coherus BioSciences (CHRS) United States $0.207B 0.00
Trevi Therapeutics (TRVI) United States $0.204B 0.00
Greenwich LifeSciences (GLSI) United States $0.204B 0.00
Biomea Fusion (BMEA) United States $0.201B 0.00
XBiotech (XBIT) United States $0.200B 0.00
Rani Therapeutics Holdings (RANI) United States $0.199B 0.00
INmune Bio (INMB) United States $0.195B 0.00
Seres Therapeutics (MCRB) United States $0.192B 0.00
Rezolute (RZLT) United States $0.192B 0.00
Puma Biotechnology (PBYI) United States $0.191B 11.97
FibroBiologics (FBLG) United States $0.190B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.189B 0.00
Skye Bioscience (SKYE) United States $0.186B 0.00
Adverum Biotechnologies (ADVM) United States $0.185B 0.00
Adherex Technologies (FENC) United States $0.184B 224.33
ScPharmaceuticals (SCPH) United States $0.183B 0.00
G1 Therapeutics (GTHX) United States $0.183B 0.00
Syros Pharmaceuticals (SYRS) United States $0.174B 0.00
Innate Pharma S.A (IPHA) France $0.174B 0.00
Adocia (ADOCY) France $0.174B 0.00
Kodiak Sciences (KOD) United States $0.170B 0.00
Lifecore Biomedical (LFCR) United States $0.169B 0.00
Invivyd (IVVD) United States $0.166B 0.00
Zura Bio (ZURA) United States $0.166B 0.00
BioStem Technologies (BSEM) $0.165B 0.00
Elevation Oncology (ELEV) United States $0.164B 0.00
Repare Therapeutics (RPTX) Canada $0.163B 0.00
Compugen (CGEN) Israel $0.162B 0.00
Vigil Neuroscience (VIGL) United States $0.162B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.153B 0.00
PDS Biotechnology (PDSB) United States $0.152B 0.00
Bluebird Bio (BLUE) United States $0.148B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.146B 0.00
DiaMedica Therapeutics (DMAC) United States $0.145B 0.00
Compass Therapeutics (CMPX) United States $0.144B 0.00
Annovis Bio (ANVS) United States $0.140B 0.00
Inventiva S.A (IVA) France $0.136B 0.00
Adlai Nortye (ANL) Cayman Islands $0.135B 0.00
Immunic (IMUX) United States $0.133B 0.00
I-Mab (IMAB) China $0.132B 0.00
Rapt Therapeutics (RAPT) United States $0.131B 0.00
Akoya Biosciences (AKYA) United States $0.130B 0.00
Athira Pharma (ATHA) United States $0.129B 0.00
Werewolf Therapeutics (HOWL) United States $0.128B 0.00
X4 Pharmaceuticals (XFOR) United States $0.128B 0.00
Nuvectis Pharma (NVCT) United States $0.127B 0.00
Seer (SEER) United States $0.125B 0.00
Opthea (OPT) Australia $0.124B 0.00
CervoMed (CRVO) United States $0.122B 0.00
Semper Paratus Acquisition (TVGN) United States $0.121B 0.00
Cellectis S.A (CLLS) France $0.121B 0.00
ATyr Pharma (ATYR) United States $0.120B 0.00
CytomX Therapeutics (CTMX) United States $0.118B 7.55
TELA Bio (TELA) United States $0.117B 0.00
Cardiff Oncology (CRDF) United States $0.116B 0.00
Omega Therapeutics (OMGA) United States $0.115B 0.00
Adagene (ADAG) China $0.115B 0.00
Coya Therapeutics (COYA) United States $0.112B 0.00
Sagimet Biosciences (SGMT) United States $0.111B 0.00
Elutia (ELUT) United States $0.108B 0.00
Adicet Bio (ACET) United States $0.105B 0.00
VistaGen Therapeutics (VTGN) United States $0.103B 0.00
BioHarvest Sciences (CNVCF) Canada $0.102B 0.00
InflaRx (IFRX) Germany $0.099B 0.00
BioAtla (BCAB) United States $0.099B 0.00
Benitec Biopharma (BNTC) United States $0.098B 0.00
Checkpoint Therapeutics (CKPT) United States $0.096B 0.00
Boundless Bio (BOLD) United States $0.095B 0.00
Sangamo Therapeutics (SGMO) United States $0.095B 0.00
BeyondSpring (BYSI) United States $0.094B 0.00
Verastem (VSTM) United States $0.093B 0.00
Eton Pharmaceuticals (ETON) United States $0.092B 89.75
Clearside Biomedical (CLSD) United States $0.091B 0.00
HilleVax (HLVX) United States $0.091B 0.00
Kronos Bio (KRON) United States $0.090B 0.00
Genelux (GNLX) United States $0.090B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.088B 0.00
IO Biotech (IOBT) Denmark $0.088B 0.00
Instil Bio (TIL) United States $0.086B 0.00
Chimerix (CMRX) United States $0.085B 0.00
Affimed (AFMD) Germany $0.085B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.084B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
Oncolytics Biotech (ONCY) Canada $0.082B 0.00
AN2 Therapeutics (ANTX) United States $0.081B 0.00
Spero Therapeutics (SPRO) United States $0.081B 2.94
LENZ Therapeutics (LENZ) United States $0.080B 0.00
DBV Technologies S.A (DBVT) France $0.080B 0.00
Cognition Therapeutics (CGTX) United States $0.079B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.077B 0.00
Gritstone Bio (GRTS) United States $0.077B 0.00
Allakos (ALLK) United States $0.074B 0.00
Ovid Therapeutics (OVID) United States $0.074B 0.00
VTv Therapeutics (VTVT) United States $0.073B 0.00
Theratechnologies (THTX) Canada $0.073B 0.00
Precision BioSciences (DTIL) United States $0.072B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.070B 0.00
Connect Biopharma Holdings (CNTB) United States $0.070B 0.00
Entera Bio (ENTX) Israel $0.069B 0.00
Vor Biopharma (VOR) $0.069B 0.00
MediciNova (MNOV) United States $0.068B 0.00
China Health Industries Holdings (CHHE) China $0.068B 0.00
Intensity Therapeutics (INTS) United States $0.067B 0.00
Genenta Science S.p.A (GNTA) Italy $0.067B 0.00
Aileron Therapeutics (ALRN) United States $0.067B 0.00
Galena Biopharma (SLS) United States $0.066B 0.00
HOOKIPA Pharma (HOOK) United States $0.065B 0.00
Eyenovia (EYEN) United States $0.063B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.063B 0.00
Enzo Biochem (ENZ) United States $0.061B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.060B 0.00
Rallybio (RLYB) United States $0.060B 0.00
Turnstone Biologics (TSBX) United States $0.060B 0.00
Celularity (CELU) United States $0.060B 0.00
Atara Biotherapeutics (ATRA) United States $0.059B 0.00
Cidara Therapeutics (CDTX) United States $0.059B 0.00
Earth Science Tech (ETST) United States $0.059B 0.00
Passage Bio (PASG) United States $0.059B 0.00
Aerovate Therapeutics (AVTE) United States $0.057B 0.00
Leap Therapeutics (LPTX) United States $0.057B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.057B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.055B 0.00
Alpha Teknova (TKNO) United States $0.055B 0.00
Immix Biopharma (IMMX) United States $0.054B 0.00
Estrella Immunopharma (ESLA) United States $0.053B 0.00
CalciMedica (CALC) United States $0.052B 0.00
ARCA Biopharma (ABIO) United States $0.052B 0.00
BioXcel Therapeutics (BTAI) United States $0.050B 0.00
Ocuphire Pharma (OCUP) United States $0.050B 0.00
NextCure (NXTC) United States $0.050B 0.00
Lantern Pharma (LTRN) United States $0.048B 0.00
Kezar Life Sciences (KZR) United States $0.047B 0.00
Lexaria Bioscience (LEXX) Canada $0.047B 0.00
Elicio Therapeutics (ELTX) United States $0.047B 0.00
Cue Biopharma (CUE) United States $0.045B 0.00
OKYO Pharma (OKYO) $0.045B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.044B 0.00
Ocean Biomedical (OCEA) United States $0.043B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.042B 0.00
Promis Neurosciences (PMN) Canada $0.042B 0.00
Fortress Biotech (FBIO) United States $0.041B 0.00
Aligos Therapeutics (ALGS) United States $0.041B 0.00
Aadi Bioscience (AADI) United States $0.041B 0.00
LakeShore Biopharma (LSB) China $0.041B 0.00
Curis (CRIS) United States $0.040B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.039B 0.00
IN8bio (INAB) United States $0.038B 0.00
Immuneering (IMRX) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
MiNK Therapeutics (INKT) United States $0.036B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.035B 0.00
Cyclo Therapeutics (CYTH) United States $0.035B 0.00
Quince Therapeutics (QNCX) United States $0.032B 0.00
Equillium (EQ) United States $0.032B 0.00
Carmell (CTCX) United States $0.032B 0.00
Pluri (PLUR) Israel $0.032B 0.00
Clene (CLNN) United States $0.031B 0.00
Lisata Therapeutics (LSTA) United States $0.031B 0.00
RenovoRx (RNXT) United States $0.030B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Bolt Biotherapeutics (BOLT) United States $0.029B 0.00
SAB Biotherapeutics (SABS) United States $0.028B 0.00
BioAffinity Technologies (BIAF) United States $0.028B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.028B 0.00
Femasys (FEMY) United States $0.027B 0.00
Beyond Air (XAIR) United States $0.027B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Biora Therapeutics (BIOR) United States $0.026B 0.00
UNITY Biotechnology (UBX) United States $0.026B 0.00
Spruce Biosciences (SPRB) United States $0.024B 0.00
HCW Biologics (HCWB) United States $0.024B 0.00
Orgenesis (ORGS) United States $0.024B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.024B 0.00
NKGen Biotech (NKGN) United States $0.023B 0.00
Cocrystal Pharma (COCP) United States $0.023B 0.00
Longeveron (LGVN) United States $0.022B 0.00
KALA BIO (KALA) United States $0.022B 0.00
Aprea Therapeutics (APRE) United States $0.022B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.021B 0.00
Forte Biosciences (FBRX) United States $0.021B 0.00
VBI Vaccines (VBIV) United States $0.021B 0.00
Cara Therapeutics (CARA) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Synlogic (SYBX) United States $0.018B 0.00
Apollomics (APLM) United States $0.018B 0.00
Sensei Biotherapeutics (SNSE) United States $0.018B 0.00
BRIACELL THERAP (BCTX) Canada $0.018B 0.00
Evaxion Biotech (EVAX) Denmark $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
Kintara Therapeutics (KTRA) United States $0.016B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Galecto (GLTO) Denmark $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
IMMURON (IMRN) Australia $0.015B 0.00
Senti Biosciences (SNTI) United States $0.014B 0.00
Imunon (IMNN) United States $0.013B 0.00
Monopar Therapeutics (MNPR) United States $0.013B 0.00
Lumos Pharma (LUMO) United States $0.013B 0.00
Chemomab Therapeutics (CMMB) Israel $0.012B 0.00
Aptose Biosciences (APTO) Canada $0.012B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.012B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.011B 0.00
AEterna Zentaris (AEZS) Canada $0.011B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.010B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Purple Biotech (PPBT) Israel $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Novogen (KZIA) Australia $0.009B 0.00
Kineta (KA) United States $0.009B 0.00
Organovo Holdings (ONVO) United States $0.009B 0.00
ANEW Medical (WENA) United States $0.009B 0.00
ABVC BioPharma (ABVC) United States $0.009B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.008B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Soligenix (SNGX) United States $0.007B 0.00
GeoVax Labs (GOVX) United States $0.007B 0.00
Bionomics (BNOX) Australia $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Silo Pharma (SILO) United States $0.007B 0.00
Notable Labs (NTBL) United States $0.007B 0.00
Telesis Bio (TBIO) United States $0.006B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Bright Minds Biosciences (DRUG) United States $0.006B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Trevena (TRVN) United States $0.005B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Psyence Biomedical (PBM) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Allarity Therapeutics (ALLR) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Portage Biotech (PRTG) $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.00
Cingulate (CING) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00